Article Abstract

Technology to overcome therapeutic inertia

Authors: Deborah A. Greenwood, Malinda Peeples

Abstract

Clinicalinertia or therapeutic inertia is a major health problem in type 2 diabetes(T2D). So much so that the American Diabetes Association (ADA) recently kickedoff a multi-year campaign to identify the issues, address barriers and developsolutions (1). Therapeutic inertia is defined as “the failure to initiate orintensify therapy in a timely manner according to evidence-basedclinical guidelines.” (2). The term therapeutic implies that both patientsand healthcare providers (HCPs) are together part of the problem and thesolution. A recent systematic review documented that on average it took morethan 1 year from the start of treatment intensification until an A1C target wasachieved (2). And in some studies, the range was more than 7 years! In the UnitedStates we are not meeting goals for diabetes management despite the multitudeof new medications on the market to manage T2D and up-to-date clinicalguidelines (3).